US COPD Coalition

Year: 2021

Mar
2

FDA Grants Emergency Use Authorization for Single-Dose Vaccine

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies, a subsidiary of Johnson & Johnson, for its single-shot COVID-19 vaccine. This marks the third vaccine to be awarded an emergency use authorization by the FDA. “This week marked a devastating milestone of 500,000 deaths from … Read more

Feb
24

NIH Announces Plans to Study “Long COVID”

Many patients who have been infected with SARS-CoV-2 experience multiple symptoms long after they have recovered from the initial stages of COVID-19 illness. The National Institutes of Health (NIH) has just announced a major new initiative to study this phenomenon with the goal of identifying its cause and how to treat and prevent it. “Often referred … Read more

Feb
19

USCC Joins Other Organizations in Advocacy Efforts

The US COPD Coalition (USCC) has recently signed on to two important letters.  One letter focuses on the need to address gaps in our system of delivery and supply of supplemental oxygen. The pandemic has put a strain on our supply of supplemental oxygen for home use due to the additional oxygen needs of COVID-19 … Read more

Feb
17

Solovy Award for Advancement in COPD: Call for Nominations

Respiratory Health Association, a member of the US COPD Coalition, invites you to submit nominations recognizing individuals who have made outstanding contributions to Chronic Obstructive Pulmonary Disease (COPD) research to improve the quality of life for those living with COPD. Purpose: This notice announces a nationwide call for award nominations for The Solovy Award for Advancement in … Read more

Feb
9

Clinical trial in hospitalized COVID-19 patients evaluates long-acting antibody therapy

The following article is re-printed from a news release by the National Institutes of Health NIH trial has begun enrolling participants. An international randomized, controlled Phase 3 clinical trial has begun evaluating the safety and efficacy of an investigational long-acting antibody combination for treating people hospitalized with COVID-19. The trial, part of a master protocol known as … Read more

Feb
1

NIH study shows hyaluronan is effective in treating chronic lung disease

The following article is re-printed from a news release by the National Institutes of Health Naturally produced by the body, hyaluronan represents a new class of biologic that significantly improves lung health in patients with severe COPD. Researchers at the National Institutes of Health and their collaborators found that inhaling unfragmented hyaluronan improves lung function … Read more

Jan
21

“COVID-19: Info You Can Trust” Webinar

What is the latest COVID-19 update? What should I know about the new strain of the virus? What do I need to know before getting a vaccine? Where do I go for answers and information that I can trust? We are nearly a full year into the COVID-19 pandemic, and we now have a deluge of information … Read more

Jan
12

What to Expect After Getting a COVID-19 Vaccine

The following is reprinted from the Centers for Disease Control & Prevention’s coronavirus website. COVID-19 vaccination will help protect you from getting COVID-19. You may have some side effects, which are normal signs that your body is building protection. These side effects may affect your ability to do daily activities, but they should go away … Read more